J Korean Surg Soc. 2010 Nov;79(5):369-376. Korean.
Published online Nov 12, 2010.
Copyright © 2010 The Korean Surgical Society
Original Article

Bacteriologic Study and Antibiotics Sensitivity of Acute Appendicitis Treated with Laparoscopic Appendectomy

Jae-Won Lee, M.D., Joong-Min Park, M.D., Seung-Eun Lee, M.D., Yong-Geum Park, M.D. and Kyong-Choun Chi, M.D.
    • Department of Surgery, Chung-Ang University College of Medicine, Seoul, Korea.
Received April 29, 2010; Accepted September 16, 2010.

Abstract

Purpose

This study was designed to evaluate the bacteriological characteristics and antibiotics sensitivity in acute appendicitis.

Methods

The microbiologic culture and antibiotics sensitivity tests were done on 165 patients who underwent laparoscopic appendectomy under the diagnosis of acute appendicitis. The postoperative complications were also checked. The microbiologic and clinical results were compared between perforated and non-perforated groups.

Results

The most common organism cultured from the periappendiceal fluid was Escherichia coli (51.2%), followed by Enterobacter (16.2%) and Pseudomonas (8.9%). In the antibiotics sensitivity test, ciprofloxacin and levofloxacin were highly susceptible. Ceftriaxone and cefotaxime were also highly susceptible. Piperacillin/tazobactam, imipenem and meropenem were very highly susceptible. The complication rate of perforated appendicitis group (17.9%) was higher than that of the non-perforated appendicitis group (7.1%) (P<0.001). A surgical drain was used more frequently in perforated group (23% vs 84.6%, P<0.001). The mean in-patient days were longer in the perforated group (5.7 vs 7.2 days, P<0.001). In the patients with infectious wound complication, antibiotic resistance was more prominent in the non-perforated group than in the perforated group.

Conclusion

In the perforated appendicitis group, more precise and careful procedure was required. In the non-perforated appendicitis group, more prudent use of the available antibiotics to conserve valuable therapeutic resources and improved infection control to limit the spread of resistant organisms was required.

Keywords
Appendicitis; Laparoscopic appendectomy; Microbiology; Antibiotics susceptibility test

Tables

Table 1
Comparison of results between simple non-perforated and perforated/abscess appendicitis

Table 2
Microorganisms cultured from appendiceal tissue or peritoneal fluid

Table 3
The antibiotics sensitivity test of the microorganisms

Table 4
The antibiotics resistance of microorganisms

Table 5
Sensitivity and resistance of microorganisms cultured from appendicitis complications between non-perforated and perforated

References

    1. Bauer T, Vennits B, Holm B, Hahn-Pedersen J, Lysen D, Galatius H, et al. The Danish Multicenter Study Group III. Antibiotic prophylaxis in acute nonperforated appendicitis. Ann Surg 1989;209:307–311.
    1. Pieper R, Kager L, Nasman P. Acute appendicitis: a clinical study of 1018 cases of emergency appendectomy. Acta Chir Scand 1982;148:51–62.
    1. Browder W, Smith JW, Vivoda LM, Nichols RL. Nonperforative appendicitis: a continuing surgical dilemma. J Infect Dis 1989;159:1088–1094.
    1. Bates T, Touquet VL, Tutton MK, Mahmoud SE, Reuther JW. Prophylactic metronidazole in appendicectomy: a controlled trial. Br J Surg 1980;67:547–550.
    1. Hopkins JA, Lee JC, Wilson SE. Susceptibility of intra-abdominal isolates at operation: a predictor of postoperative infection. Am Surg 1993;59:791–796.
    1. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606–608.
    1. Busuttil RW, Davidson RK, Fine M, Tompkins RK. Effect of prophylactic antibiotics in acute nonperforated appendicitis: a prospective, randomized, double-blind clinical study. Ann Surg 1981;194:502–509.
    1. Putnam TC, Gagliano N, Emmens RW. Appendicitis in children. Surg Gynecol Obstet 1990;170:527–532.
    1. Yau KK, Siu WT, Tang CN, Yang GP, Li MK. Laparoscopic versus open appendectomy for complicated appendicitis. J Am Coll Surg 2007;205:60–65.
    1. Park JB, Sul JY. Laparoscopic appendectomy: a safe primary procedure for complicated appendicitis. J Korean Surg Soc 2007;72:51–56.
    1. Kooi GH, Pit S. Ceftazidime/metronidazole versus netilmicin/metronidazole in the treatment of perforated appendicitis in children. Clin Ther 1990;12:54–60.
    1. Kim KJ, Jun HJ, Ryu JW, Park DG, Chung M, Kim JT, et al. A bacteriologic investigation of the acute appendicitis. J Korean Surg Soc 1997;52:122–127.
    1. Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002;8:278–282.
    1. Yun SJ, Koh YT, Sim MS, Suh DY, Park DS. Culture-sensitivity test and infectious complication in perforated appendicitis. J Korean Soc Coloproctol 2000;16:73–77.
    1. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010;50:133–164.
    1. Wullstein C, Barkhausen S, Gross E. Results of laparoscopic vs. conventional appendectomy in complicated appendicitis. Dis Colon Rectum 2001;44:1700–1705.
    1. Park JM, Kim J, Kim CY, Choi DJ, Kim SH, Kim CS, et al. Laparoscopic appendectomy: a safe procedure that can be performed by surgical residents. J Korean Surg Soc 2008;75:315–322.
    1. Livermore DM. Minimising antibiotic resistance. Lancet Infect Dis 2005;5:450–459.
    1. Wise R. The relentless rise of resistance? J Antimicrob Chemother 2004;54:306–310.
    1. Gladman MA, Knowles CH, Gladman LJ, Payne JG. Intra-operative culture in appendicitis: traditional practice challenged. Ann R Coll Surg Engl 2004;86:196–201.
    1. Nagai A, Miyazaki M, Morita T, Furubo S, Kizawa K, Fukumoto H, et al. Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs. J Toxicol Sci 2002;27:219–228.

Metrics
Share
Tables

1 / 5

PERMALINK